Cargando…
Calprotectin in viral systemic infections—COVID-19 versus hepatitis C virus
This study aims to evaluate differences in serum and fecal calprotectin in patients with HCV chronic hepatitis and COVID-19 infection and compare them to a control group. This observational study was performed between April 2020 and October 2020 in a single Internal Medicine center. We determined se...
Autores principales: | Toma, Letitia, Dodot, Mihai, Zgura, Anca, Bacalbasa, Nicolae, Silaghi, Andrei, Simu, Razvan, Isac, Teodora, Mercan-Stanciu, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274470/ https://www.ncbi.nlm.nih.gov/pubmed/34254197 http://dx.doi.org/10.1007/s10238-021-00743-7 |
Ejemplares similares
-
A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing
por: Badiu, Dumitru Cristinel, et al.
Publicado: (2021) -
Electrocardiographic Changes in Liver Cirrhosis—Clues for Cirrhotic Cardiomyopathy
por: Toma, Letitia, et al.
Publicado: (2020) -
Multimodal Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antivirals
por: Mercan-Stanciu, Adriana, et al.
Publicado: (2022) -
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
por: Iliescu, Elena Laura, et al.
Publicado: (2020) -
Mesenteric Ischemia in a Patient with Essential Thrombocythemia: Does COVID-19 Play Any Role? A Case Report and Overview of the Literature
por: Cotorogea-Simion, Mihail, et al.
Publicado: (2022)